Compare, Analyse Biocon Ltd with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs MYLAN (US) - Comparison Results

BIOCON      Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 BIOCON    MYLAN
EQUITY SHARE DATA
    BIOCON
Mar-19
MYLAN
Dec-18
BIOCON /
MYLAN
5-Yr Chart
Click to enlarge
High Rs7073,578-   
Low Rs5541,969-   
Sales per share (Unadj.) Rs91.91,646.4-  
Earnings per share (Unadj.) Rs16.744.7-  
Cash flow per share (Unadj.) Rs24.2353.0-  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs101.61,781.1-  
Shares outstanding (eoy) m600.00514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.91.7 407.2%   
Avg P/E ratio x37.762.0 60.8%  
P/CF ratio (eoy) x26.17.9 331.9%  
Price / Book Value ratio x6.21.6 398.4%  
Dividend payout %6.00-   
Avg Mkt Cap Rs m378,3301,427,106 26.5%   
No. of employees `0006.135.0 17.5%   
Total wages/salary Rs m11,6530-   
Avg. sales/employee Rs Th8,994.324,202.6 37.2%   
Avg. wages/employee Rs Th1,900.70-   
Avg. net profit/employee Rs Th1,635.3657.2 248.8%   
INCOME DATA
Net Sales Rs m55,144847,091 6.5%  
Other income Rs m1,4440-   
Total revenues Rs m56,588847,091 6.7%   
Gross profit Rs m15,883219,196 7.2%  
Depreciation Rs m4,478158,609 2.8%   
Interest Rs m70940,742 1.7%   
Profit before tax Rs m12,14019,845 61.2%   
Minority Interest Rs m90-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,123-3,157 -67.2%   
Profit after tax Rs m10,02623,002 43.6%  
Gross profit margin %28.825.9 111.3%  
Effective tax rate %17.5-15.9 -109.9%   
Net profit margin %18.22.7 669.6%  
BALANCE SHEET DATA
Current assets Rs m48,228473,015 10.2%   
Current liabilities Rs m30,376344,880 8.8%   
Net working cap to sales %32.415.1 214.0%  
Current ratio x1.61.4 115.8%  
Inventory Days Days6884 81.7%  
Debtors Days Days8693 91.6%  
Net fixed assets Rs m64,130164,322 39.0%   
Share capital Rs m3,000451 665.2%   
"Free" reserves Rs m57,9800-   
Net worth Rs m60,980916,397 6.7%   
Long term debt Rs m15,766989,087 1.6%   
Total assets Rs m121,9242,458,134 5.0%  
Interest coverage x18.11.5 1,218.7%   
Debt to equity ratio x0.31.1 24.0%  
Sales to assets ratio x0.50.3 131.2%   
Return on assets %8.82.6 339.5%  
Return on equity %16.42.5 655.0%  
Return on capital %16.83.2 526.9%  
Exports to sales %28.10-   
Imports to sales %18.90-   
Net fx Rs m5,1070-   
CASH FLOW
From Operations Rs m11,546176,026 6.6%  
From Investments Rs m-7,138-90,986 7.8%  
From Financial Activity Rs m-2,417-82,003 2.9%  
Net Cashflow Rs m2,1031,458 144.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 75.17 Rs / USD

Compare BIOCON With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare BIOCON With: GSK PHARMA  FRESENIUS KABI ONCO.  DR. DATSONS LABS  FDC LTD.  LUPIN  



Today's Market

SGX Nifty Trades Higher, PNB Reports DHFL Fraud, TCS June Quarter Numbers, and Top Buzzing Stocks Today(Pre-Open)

Indian share markets witnessed selling pressure on Friday, tracking weak global cues as coronavirus cases continue to surge across the world.

Related Views On News

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, BIOCON has posted a net profit of Rs 3 bn (down 30.5% YoY). Sales on the other hand came in at Rs 16 bn (up 19.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1 (Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Two Agri Stocks Are Likely to Outperform Even in this Market (Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

A Warning for Traders: Don't Get Addicted to Hopium (Fast Profits Daily)

Jun 30, 2020

If you are a trader, you must watch out for this dangerous addiction.

Smallcaps Are in a Sweet Spot Again: Are You Buying? (Profit Hunter)

Jul 3, 2020

This is why I believe smallcaps are the place to be in the near future.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2020
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

BIOCON SHARE PRICE


Jul 10, 2020 (Close)

TRACK BIOCON

MORE ON BIOCON

BIOCON 8-QTR ANALYSIS

COMPARE BIOCON WITH

FEATURED VIDEOS

MARKET STATS